Li Xiaofang, Tian Run, Gao Hugh, Yan Feng, Ying Le, Yang Yongkang, Yang Pei, Gao Yan'e
1 Department of Obstetrics and Gynecology, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, People's Republic of China.
2 Department of Orthopedics, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, People's Republic of China.
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818767455. doi: 10.1177/1533033818767455.
Cervical cancer is the leading cause of death with gynecological malignancies. We aimed to explore the molecular mechanism of carcinogenesis and biomarkers for cervical cancer by integrated bioinformatic analysis. We employed RNA-sequencing details of 254 cervical squamous cell carcinomas and 3 normal samples from The Cancer Genome Atlas. To explore the distinct pathways, messenger RNA expression was submitted to a Gene Set Enrichment Analysis. Kyoto Encyclopedia of Genes and Genomes and protein-protein interaction network analysis of differentially expressed genes were performed. Then, we conducted pathway enrichment analysis for modules acquired in protein-protein interaction analysis and obtained a list of pathways in every module. After intersecting the results from the 3 approaches, we evaluated the survival rates of both mutual pathways and genes in the pathway, and 5 survival-related genes were obtained. Finally, Cox hazards ratio analysis of these 5 genes was performed. DNA replication pathway ( P < .001; 12 genes included) was suggested to have the strongest association with the prognosis of cervical squamous cancer. In total, 5 of the 12 genes, namely, minichromosome maintenance 2, minichromosome maintenance 4, minichromosome maintenance 5, proliferating cell nuclear antigen, and ribonuclease H2 subunit A were significantly correlated with survival. Minichromosome maintenance 5 was shown as an independent prognostic biomarker for patients with cervical cancer. This study identified a distinct pathway (DNA replication). Five genes which may be prognostic biomarkers and minichromosome maintenance 5 were identified as independent prognostic biomarkers for patients with cervical cancer.
宫颈癌是妇科恶性肿瘤的主要致死原因。我们旨在通过综合生物信息学分析来探索宫颈癌的致癌分子机制和生物标志物。我们利用了来自癌症基因组图谱的254例宫颈鳞状细胞癌和3例正常样本的RNA测序数据。为了探索不同的通路,将信使RNA表达提交至基因集富集分析。进行了京都基因与基因组百科全书分析以及差异表达基因的蛋白质-蛋白质相互作用网络分析。然后,我们对蛋白质-蛋白质相互作用分析中获得的模块进行通路富集分析,并获得每个模块中的通路列表。在将这三种方法的结果进行交叉分析后,我们评估了共同通路和通路中基因的生存率,获得了5个与生存相关的基因。最后,对这5个基因进行了Cox风险比分析。DNA复制通路(P <.001;包括12个基因)被认为与宫颈鳞状癌的预后关联最强。在这12个基因中,共有5个基因,即微小染色体维持蛋白2、微小染色体维持蛋白4、微小染色体维持蛋白5、增殖细胞核抗原和核糖核酸酶H2亚基A与生存显著相关。微小染色体维持蛋白5被证明是宫颈癌患者的独立预后生物标志物。本研究确定了一条独特的通路(DNA复制)。鉴定出了5个可能作为预后生物标志物的基因,其中微小染色体维持蛋白5被确定为宫颈癌患者的独立预后生物标志物。